Vossman discusses the genomics landscape, as well as next-generation sequencing (or NGS), and the Model Project, a ...

Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO ...

FOSTER CITY, CA, UNITED STATES, November 10, 2025 /EINPresswire.com/ -- DeepSeq.AI, Inc. (DeepSeq), a privately held biotech company transforming AI-based protein ...

Following global commercial launch in September, Illumina Protein Prep's "out of the box" solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed ...

Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ban. The $1.08 billion it brought in for the third quarter was, however, ...

The Genomics Core offers a wide range of DNA library preps from whole-genome PCR free to amplicon sequencing and CRISPR-Cas 9 validation. We also work with users to complete ChIP-seq and CUT&RUN ...

Oct 21 (Reuters) - Biotech company 10x Genomics (TXG.O), opens new tab filed two lawsuits against rival Illumina (ILMN.O), opens new tab in Delaware federal court on ...

Illumina has launched Protein Prep, an assay that measures up to 9,500 unique human protein targets using next-generation sequencing (NGS). The platform is designed to integrate proteomic data into ...

Illumina, Inc. ILMN recently announced the launch of Illumina Protein Prep, an assay designed to deliver superior performance for next-generation sequencing (NGS)-based proteomics discovery at scale.

The U.S. next-generation sequencing library preparation market size is calculated at USD 652.65 million in 2024, grows to USD 738.21 million in 2025, and is projected to reach around USD 2,237.13 ...